Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: PolyPid Ltd.

Market Cap 89.35M 77.7M 71.42M 67.25M 126M 8.45B 127M 849M 330M 4.14B 335M 328M 14.34B P/E 2026 *
-3.19x
P/E 2027 * -3.63x
Enterprise Value 89.35M 77.7M 71.42M 67.25M 126M 8.45B 127M 849M 330M 4.14B 335M 328M 14.34B EV / Sales 2026 *
-
EV / Sales 2027 * 6.53x
Free-Float
78.77%
Yield 2026 *
-
Yield 2027 * -
1 day-2.15%
1 week-0.22%
Current month-3.39%
1 month+2.24%
3 months+3.64%
6 months+15.44%
Current year+5.07%
1 week 4.5
Extreme 4.5
4.82
1 month 4.4
Extreme 4.4
5.21
Current year 4.01
Extreme 4.01
5.21
1 year 3.06
Extreme 3.06
5.21
3 years 2.3
Extreme 2.3
12.6
5 years 2.3
Extreme 2.3
289.2
10 years 2.3
Extreme 2.3
583.5
Manager TitleAgeSince
Chief Executive Officer 52 2022-06-30
Director of Finance/CFO 39 -
Chief Tech/Sci/R&D Officer 60 2025-08-17
Director TitleAgeSince
Director/Board Member 84 2008-03-31
Director/Board Member 52 2022-08-07
Director/Board Member 74 2018-11-30
Date Insider Type Main position Quantity % Market Cap.
03-17Other

Director

23,293 0.1221%
03-17Other

Chairman

17,456 0.0915%
03-17Other

Director

22,660 0.1187%
Change 5-day change 1-year change 3-year change Capi.($)
-2.15%-0.22%+24.25%-63.80% 89.35M
-0.94%-2.85%+37.70%+148.38% 1,001B
-0.42%-1.18%+50.88%+42.60% 566B
-0.56%-1.86%+15.91%+59.57% 393B
-1.18%+2.29%+24.04%+16.53% 326B
+1.09%+2.21%+25.56%+33.32% 276B
+1.42%-1.17%+24.53%+14.29% 277B
+1.87%+5.96%-42.67%-48.26% 193B
-1.78%-0.84%+15.60%+48.77% 188B
-1.40%-0.04%+13.19%+59.08% 158B
Average -0.16%+0.52%+18.90%+31.05% 337.69B
Weighted average by Cap. -0.25%-0.41%+27.02%+66.26%

Financials

2026 *2027 *
Net sales - 13.68M 11.89M 10.93M 10.29M 19.28M 1.29B 19.5M 130M 50.43M 634M 51.32M 50.22M 2.2B
Net income -33.91M -29.49M -27.11M -25.52M -47.8M -3.21B -48.36M -322M -125M -1.57B -127M -125M -5.44B -32.76M -28.49M -26.19M -24.66M -46.18M -3.1B -46.72M -311M -121M -1.52B -123M -120M -5.26B
Net Debt - -
Logo PolyPid Ltd.
Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.
Employees
72
Date Price Change Volume
26-06-17 4.560 $ -2.15% 24,327
26-06-16 4.660 $ -0.11% 58,208
26-06-15 4.665 $ +0.97% 34,096
26-06-12 4.620 $ +1.09% 61,881
26-06-11 4.570 $ +1.33% 103,116
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
4.660USD
Average target price
12.25USD
Spread / Average Target
+162.88%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. PYPD Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!